S. Chander

M. Dowsett, R. Coombes, S. Chander, 1993, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

The biological evaluation of novel antioestrogens for the treatment of breast cancer.

Y. Luqmani, S. Chander, T. Evans, 1993, Critical reviews in oncology/hematology.

Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents

B. Potter, A. Purohit, M. Reed, 2004, British Journal of Cancer.

The regulation and inhibition of 17β-hydroxysteroid dehydrogenase in breast cancer

H. Tutill, J. Day, A. Purohit, 2006, Molecular and Cellular Endocrinology.

Steroid sulphatase inhibitors for breast cancer therapy

B. Potter, A. Purohit, M. Reed, 2003, The Journal of Steroid Biochemistry and Molecular Biology.

Clinical and biological significance of HSP89 alpha in human breast cancer

R. Coombes, Y. Luqmani, S. Chander, 1992, International journal of cancer.

First dual aromatase-steroid sulfatase inhibitors.

B. Potter, A. Purohit, M. Reed, 2003, Journal of medicinal chemistry.

The effects of 2-methoxyoestrogen sulphamates on the in vitro and in vivo proliferation of breast cancer cells

A. Purohit, M. Reed, S. Newman, 2005, The Journal of Steroid Biochemistry and Molecular Biology.

The effect of endocrine therapy on fibroblast growth factor-like activity in nitrosomethylurea-induced rat mammary tumours.

R. Coombes, S. Chander, R. Baillie, 1993, European journal of cancer.

Efficacy of three potent steroid sulfatase inhibitors: pre-clinical investigations for their use in the treatment of hormone-dependent breast cancer

B. Potter, A. Purohit, M. Reed, 2008, Breast Cancer Research and Treatment.

The in vivo properties of STX243: a potent angiogenesis inhibitor in breast cancer

B. Potter, A. Purohit, M. Reed, 2008, British Journal of Cancer.

Inhibition of MCF-7 breast cancer cell proliferation and in vivo steroid sulphatase activity by 2-methoxyoestradiol-bis-sulphamate

B. Potter, A. Purohit, M. Reed, 2003, The Journal of Steroid Biochemistry and Molecular Biology.

Inhibition of steroid sulphatase activity via the percutaneous route: a new option for breast cancer therapy.

B. Potter, A. Purohit, M. Reed, 2008, Anticancer research.

Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template.

B. Potter, K. Acharya, A. Purohit, 2010, Journal of medicinal chemistry.

Development of a sensitive high-performance liquid chromatography method for the detection of 667 COUMATE in vivo

B. Potter, A. Purohit, M. Reed, 2003, The Journal of Steroid Biochemistry and Molecular Biology.

Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallography

C. Supuran, B. Potter, A. Purohit, 2008, Molecular Cancer Therapeutics.

Structure-activity relationships of C-17-substituted estratriene-3-O-sulfamates as anticancer agents.

B. Potter, A. Purohit, S. Newman, 2011, Journal of medicinal chemistry.

The role of steroid sulphatase in regulating the oestrogenicity of oestrogen sulphamates.

B. Potter, A. Purohit, M. Reed, 2004, Biochemical and biophysical research communications.

Dual aromatase-sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activity (vol 5, pg 2940, 2007)

A. Purohit, M. Reed, S. Chander, 2007 .

Novel D-ring modified steroid derivatives as potent, non-estrogenic, steroid sulfatase inhibitors with in vivo activity

B. Potter, A. Purohit, M. Reed, 2003, The Journal of Steroid Biochemistry and Molecular Biology.

A New Therapeutic Strategy against Hormone-Dependent Breast Cancer: The Preclinical Development of a Dual Aromatase and Sulfatase Inhibitor

B. Potter, Shiuan Chen, A. Purohit, 2008, Clinical Cancer Research.